EPCAM and cancer: Further characterization of the CD24−/CD44+ BCSC-like subset with other stem cell markers revealed that estrogen-induced breast tumor initiating/cancer stem cells acquire additional phenotypes, such as 49f, EpCam, ALDH1, and CD133 [19].